Hydroxychloroquine, Radiation, and Temozolomide Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Clinical trial NCT00486603 · COMPLETED
Trial details
- NCT number
- NCT00486603
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-29
- Primary completion
- 2013-06-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.